Lv11
20 积分 2023-06-26 加入
Dismantling relapsed/refractory mantle cell lymphoma
4小时前
待确认
How I manage mantle cell lymphoma: indolent versus aggressive disease
6小时前
已完结
Real‐world experience of axicabtagene ciloleucel, a CD19‐directed CAR T‐cell therapy, in the second‐line treatment of early relapsed or primary refractory large B‐cell lymphoma
2天前
已完结
Diagnosis and management of bispecific T cell–engaging antibody toxicity: A primer for emergency physicians
5天前
已完结
CAR T-cell Therapy for Central Nervous System Lymphoma
8天前
已完结
Outcomes for patients with secondary CNS involvement in relapsed/refractory diffuse large B-cell lymphoma and estimation of eligibility for CAR T-cell therapy
8天前
已完结
Comparative real-world outcomes of CD19-directed CAR T-cell therapies in large B-cell lymphoma
10天前
已完结
Relapsed/refractory diffuse large B-cell lymphoma patients. A multicenter retrospective analysis of eligibility criteria for car-T cell therapy
11天前
已完结
CD19 CAR-T treatment shows limited efficacy in r/r DLBCL with double expression and TP53 alterations
13天前
已完结
Five-Year Follow-Up of Standard-of-Care Axicabtagene Ciloleucel for Large B-Cell Lymphoma: Results From the US Lymphoma CAR T Consortium
18天前
已完结
不同加工方法梅花鹿鹿茸中尿嘧啶等五种核苷成分的含量分析
1年前
已采纳
皖公网安备34019202002308
